fashion -WSS

fashion

author：fashion 2025-09-27 10:01:00 - browse：8896

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： FDA approves Recor Medical high blood pressure device

entertainment

explore

WSS

Dogs on Prozac: What pet anti

Dogs on Prozac: What pet anti

Senate panel clears PBM, hopsital reforms

Getting Alzheimer's drug Leqembi to patients can be a challenge

Getting Alzheimer's drug Leqembi to patients can be a challenge

Sanofi CEO defends move to abandon profit guidance, boost research

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Apple is now the first public company to be valued at $3 trillion

Just how powerful is the placebo effect?

Affirmative action in medical school literally saved lives

Orangutan used medicinal plant to treat wound, first time ever seen

Continuity nursing helped my family in our darkest PICU moments

H5N1 bird flu virus started spreading in cows in Texas in December

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approves potent Eli Lilly obesity drug, Zepbound

Jerome Adams on the need for new antivirals for Covid

H5N1 bird flu found in pasteurized milk: what we know

entertainment

Key Senate committee drafts bipartisan bill to stem drug shortages

10 million people disenrolled from Medicaid over past six months

Removing probiotics from the NICU could threaten preemies' health

Diversify hospital leadership teams to protect BIPOC patient health

Element Biosciences CEO lays out genome sequencing strategy

Why rehabilitation engineers need to center patients in their research

entertainment

explore

entertainment

hotspot